Megumi Watanabe

Combination therapy with transductive anti‐death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat

S. Ohta, Takashi Mori, H. Igarashi, 2008 .

Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat.

S. Ohta, Takashi Mori, H. Igarashi, 2008, Journal of neurochemistry.

FK506 facilitates the normalization of post-ischemic perturbation of protein kinases and tyrosine phosphorylation in the gerbil hippocampal CA1 sectors

K. Katsura, Y. Katayama, Kumiko Takahashi, 2003 .

Thrombosis in Japanese patients with Fabry disease

Y. Iino, K. Katsura, Y. Katayama, 2009, Journal of the Neurological Sciences.

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals

Yasuo Katayama, Shigeo Ohta, K. Nishimaki, 2007, Nature Medicine.

Involvement of mitoKATP channel in protective mechanisms of cerebral ischemic tolerance

S. Ohta, K. Katsura, Y. Katayama, 2008, Brain Research.